Strategy of antibiotic rotation: Long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia

Critical Care Medicine

Volumn 31, Issue 7, 2003, Pages 1908-1914

  Gruson, Didier ^a   Hilbert, Gilles ^a   Vargas, Frederic ^a   Valentino, Ruddy ^a   Bui, Nam ^a   Pereyre, Sabine ^a   Bebear, Christianne ^a   Bebear, Cecile Marie ^a   Gbikpi Benissan, Georges ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Antibiotic resistance; Intensive care unit; Nosocomial pneumonia; Rotation of antibiotics

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; ISEPAMICIN; NETILMICIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ASSISTED VENTILATION; BACTERIAL PNEUMONIA; BURKHOLDERIA CEPACIA; DRUG CHOICE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREATMENT PLANNING;

EID: 0042851756     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000069729.06687.DE     Document Type: Article

References (29)

1. Kollef MH, Sherman G, Ward S, et al: Inadequate antimicrobial treatment of infections. A risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474
2. Murthy R: Implementation of strategies to control antimicrobial resistance. Chest 2001; 119:405S-411S.
3. Weinstein RA: Nosocomial infection update. Emerg Infect Dis 1998; 4:416-420
4. Public Health Initiative Research Institute: Report From the Bacterial Antibiotic Resistance Group/Infectious Disease Center. Washington, DC: US Government Printing Office, 1997
5. Jones RN: Resistance patterns among nosocomial pathogens. Trends over the past few years. Chest 2001; 119:397S-404S.
6. Gruson D, Hilbert G, Vargas F, et al: Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator associated pneumonia caused by antibiotic resistant Gram-negative bacteria. Am J Respir Crit Care Med 2000; 162:837-843
7. ATS Statement: Hospital acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. Am J Respir Crit Care Med 1996; 153:1711-1725
8. Thuong M, Shortgen F, Zazempa V, et al: Appropriate use of restricted antimicrobial agents in hospitals: The importance of empirical therapy and assisted re-evaluation. J Antimicrob Chemother 2000; 46:501-508
9. Kollef MH, Vlasnik J, Sharpless L, et al: Scheduled change of antibiotic classes. A strategy to decrease the incidence of ventilator associated pneumonia. Am J Respir Crit Care Med 1997; 156:1040-1048
10. Niederman MS: Is crop rotation of antibiotics the solution to "resistant" problem in the ICU? Am J Respir Crit Care Med 1997; 156:1029-1031
11. Raymond DP, Pelletier SJ, Crabtree TD, et al: Impact of a rotating empiric schedule on infectious mortality in an intensive care unit. Crit Care Med 2001; 29:1101-1108
12. Fagon JY, Chastre J, Domart Y, et al: Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139:877-884
13. Spencer RC: Predominant pathogens found in the European prevalence of infection in intensive care study. Eur J Clin Microbiol Infect Dis 1996; 15:281-285
14. Chastre J, Fagon JY: Ventilator-associated pneumonia. State of the art. Am J Respir Crit Care Med 2002; 168:867-903
15. American Thoracic Society: Hospital acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society. Am J Respir Crit Care Med 1996; 153-1711-1725
16. Rello J, Sa-Borges M, Correa H, et al: Variations in etiology of ventilator associated pneumonia across four treatment sites: Implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160:608-613
17. Trouillet JL, Chastre J, Vuagnat A, et al: Ventilator associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539
18. Chastre J, Trouillet JL, Vuagnat A, et al: Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 157:1165-1172
19. Rello J, Torres A: Microbial causes of ventilator associated pneumonia. Semin Respir Infect 1996; 11:24-31
20. National Nosocomial Infections Surveillance (NNIS) system: National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27:520-532
21. Mathai D, Lewis MT, Kugler KC, et al: Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia I. Results from the SENTRY Antimicrobial Surveillance Program (North America, 1998). Diagn Microbiol Infect Dis 2001; 39:105-116
22. McGowan JE: Is antimicrobial resistance in hospital microorganisms related to antibiotic use? Bull NY Acad Med 1987; 63:253-268
23. Shlaes DM, Gerding DN, John JF, et al: Guidelines for the prevention of antimicrobial resistance in hospitals: Joint statement by the Society for Health Care Epidemiology of American and the Infectious Diseases Society of America. Infect Control Hosp Epidemiol 1997; 18:275-291
24. McGowan JE, Gerding D: Does antibiotic restriction prevent resistance? New Horiz 1996; 4:370-376
25. Rahal JJ, Urban C, Horn D, et al: Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280:1233-1237
26. Kollef MH, Sharpless L, Vlasnik J, et al: The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest 1997; 112:666-675
27. Seppala H, Klaukka T, Vuopio-Varkila J, et al: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337:441-446
28. Davidson R, Cavalcanti R, Brunton JL, et al: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 2002; 346:747-750
29. Legall JR, Lemershow RS, Saulnier F: New simplified acute physiologic score (SAPS II) based on a European North American multicenter study. JAMA 1993; 270:2957-2963